Notice Information
Notice Title
Cytokine Modulators
Notice Description
The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a "Lot". Full details of each Lots are contained in section II.2 of this notice.
Lot Information
Etanercept
This Lot is for the supply of Etanercept 10mg, 25mg, 50mg presentations to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. Each product line has been treated as an individual Lot and is awarded on a line by line basis. This Lot was awarded as an unranked multi supplier Framework to three (3) suppliers.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
InfliximabThis Lot is for the supply Infliximab 100mg powder for concentrate for solution for infusion to NHS Scotland. This Lot has been awarded as an unranked multi supplier Framework and awarded to five (5) suppliers.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection deviceThis Lot is for the supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded as an unranked multi-supplier Framework Agreement for the Lot to two (2) suppliers.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Methotrexate (25 mg per 1 ml concentration ) pre-filled syringesThis Lot is for the supply of Methotrexate (25 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded a an unranked multi-supplier Framework Agreement for the Lot and to one (1) supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection deviceThis Lot is for the supply of Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded a an unranked multi-supplier Framework Agreement for the Lot and to one (1) supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000557325
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC340063
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £107,012,831 £100M-£1B
- Lots Value
- £106,967,156 £100M-£1B
- Awards Value
- Not specified
- Contracts Value
- £89,735,964 £10M-£100M
Notice Dates
- Publication Date
- 13 Dec 20187 years ago
- Submission Deadline
- 24 Oct 2018Expired
- Future Notice Date
- Not specified
- Award Date
- 19 Nov 20187 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Postcode Area
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP332008
Cytokine Modulators - The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC340063
Cytokine Modulators - The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a "Lot". Full details of each Lots are contained in section II.2 of this notice.
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.